Analyst Reco.

02-16 AlphaValue/Baader Europe Adjusts Exor Earnings Estimates After Stellantis' Preliminary H2 2025 Results MT
02-13 Exor: EPS cut (2025: -34.6%, 2026: -29.4%) Alphavalue
26/09/25 Exor: Exor H1 2025: Strategy still in waiting Alphavalue
17/09/25 The day the Fed resumed its rate cuts Zonebourse
02/07/25 Exor: Target upgrade by 17.8% Alphavalue
27/03/25 Exor: Exor's strategic moves: Market lagging behind Alphavalue
26/03/25 BNP Paribas Exane Upgrades Exor to Outperform MT
03/12/24 Exor: Adjustments following Exor's reclassification as an Investment Entity Alphavalue
02/12/24 Exor: Stellantis' woes likely to spill over to Exor Alphavalue
02/10/24 KBC Securities Starts Exor at Buy MT
25/09/24 Exor: NAV progresses further Alphavalue
23/07/24 AlphaValue/Baader Europe Upgrades Exor to Buy, Raises PT MT
23/07/24 Exor: Opinion change, from Add to Buy Alphavalue
11/04/24 Exor: Stellantis and Ferrari continue to push Exor forward Alphavalue
05/03/24 Exor: Exor is adept for recovery bets Alphavalue
19/02/24 Exor: NAV cut by -8.8% Alphavalue
01/12/23 EXOR : Exor reiterates its faith in Philips Alphavalue
14/09/23 EXOR : Exor pushes the throttle Alphavalue
16/08/23 EXOR : Exor delivers on its diversification strategy Alphavalue
03/07/23 EXOR : EPS upgrade (2022: -20.5%, 2023: +13.5%) Alphavalue
30/05/23 Analysts recommendations: Alliant Energy, Coinbase, Constellation Brands, Medtronic... Zonebourse
17/04/23 EXOR : 2022: Another milestone year in Exor's Equity Story Alphavalue
19/01/23 EXOR : All eyes on Juventus with Exor and Stellantis potentially impacted Alphavalue
02/12/22 EXOR : Momentous FY 22, well positioned in tough times Alphavalue
09/09/22 EXOR : Exor is not invincible Alphavalue
No results for this search